Park Medi World Limited Link 
Allotment
The Park Medi World Ltd. IPO is a book-built issue of ₹920 crore, comprising a fresh issue of 4.75 crore shares aggregating to ₹770 crore and an offer for sale of 0.93 crore shares aggregating to ₹150 crore.
The IPO was open for bidding from December 10, 2025, to December 12, 2025, with the allotment finalized on December 15, 2025. The shares were subsequently listed on BSE and NSE on December 17, 2025.
The price band was set at ₹162 per share. The lot size for applications was 92 shares, making the minimum investment for retail investors ₹14,904 (92 shares at the upper price). For small NII (sNII) investors, the minimum application was 14 lots (1,288 shares), amounting to ₹2,08,656, and for big NII (bNII) investors, it was 68 lots (6,256 shares), totaling ₹10,13,472.
Nuvama Wealth Management Ltd. acted as the book running lead manager, while Kfin Technologies Ltd. served as the registrar for the issue.
For detailed information, refer to the Park Medi World IPO Draft Red Herring Prospectus (DRHP).
₹162
0%
Open
₹162
HIgh - Low
₹162
Previous Close
₹162
Total Traded Value
0
52 Weeks High
₹162
52 Weeks Low
₹162
Updates On
Dec 1, 2025
IPO. Open
Dec 10, 2026
IPO. Close
Dec 12, 2026
IPO. Price
₹162.00
IPO Market price
₹6,997.28 Cr
IPO Details
| IPO Date | 17 Dec |
| IPO Listing Date | 17 Dec |
| IPO Face Value | ₹2 per share |
| IPO Price Range | ₹162.00 |
| IPO Issue Size | 5,67,90,123 shares |
| IPO Sale Type | Fresh Capital & OFS |
| Employee Discount | - |
| IPO Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE Platform |
| Share Holding Pre Issue | 38,43,99,990 shares |
IPO Timeline
| IPO Open Date | 10 Dec |
| IPO Close Date | 12 Dec |
| IPO Allotment (Tentative) | 15 Dec |
| Refunds | 16 Dec |
| Credit to Demat Account | 16 Dec |
| IPO Listing Date | 17 Dec |
IPO Reservation
| Category | Offer |
|---|---|
| QIB Shares Offered | 2,83,95,060 (50.00%) Shares |
| NII (HNI) Shares Offered | 85,18,519 (15.00%) Shares |
| Retail Shares Offered | 1,98,76,544 (35.00%) Shares |
IPO Lot Size
Investors can bid for a minimum of 92 shares, and in multiples of 92 shares thereafter.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 92 | ₹14,904 |
| Retail (Max) | 13 | 1,196 | ₹1,93,752 |
| S-HNI (Min) | 14 | 1,288 | ₹2,08,656 |
| S-HNI (Max) | 67 | 6,164 | ₹9,98,568 |
| B-HNI (Min) | 68 | 6,256 | ₹10,13,472 |
Incorporated in 2011, Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025.
The company operates 14 multi-super speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight hospitals are also accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network spans Haryana, Delhi, Punjab, and Rajasthan.
Park Medi World offers over 30 super speciality and speciality services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
As of September 30, 2025, the hospitals were equipped with 870 ICU beds, 67 operating theatres (OTs), and an oxygen generation plant at each location to support critical care. The hospital locations include Haryana (Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad), Delhi, Punjab (Patiala, Mohali), and Rajasthan (Jaipur, Behror).
The company had a workforce of 1,014 doctors and 2,142 nurses as of September 30, 2025.
Competitive Strengths :
Second largest private hospital chain in North India and largest in Haryana
Delivering high-quality, affordable healthcare with a diverse specialty mix
Proven track record in acquiring and integrating hospitals
Strong operational and financial performance with a diversified payor mix
Doctor-led professional management team with extensive industry experience
Company Financials (Consolidated)
| Assets | 2,320.93 | 2,133.70 | 1,912.10 |
| Total Income | 823.39 | 1,425.97 | 1,263.08 |
| Profit After Tax | 139.14 | 213.22 | 152.01 |
| EBITDA | 217.14 | 372.17 | 310.3 |
| NET Worth | 1,153.05 | 1,021.86 | 815.98 |
| Reserves and Surplus | 1,187.77 | 1,049.40 | 858.63 |
| Total Borrowing | 733.91 | 682.07 | 686.71 |
Key Performance Indicator (KPI)
| ROE | 21% |
| ROCE | 17% |
| Debt/Equity | 0.61 |
| RoNW | 20.08% |
| PAT Margin | 15.30% |
| EBITDA Margin | 26.71% |
| Price to Book Value | 6.09 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | 245.32 |
| 4 | Offer for Sale (OFS) | - |
Contact Details
Park Medi World Ltd.
12, Meera Enclave Near Keshopur,
Bus Depot, Outer Ring Road,
New Delhi 110018, Delhi
New Delhi, New Delhi, 110018
Phone: + 91 124 696 000
Email: company.secretary@parkhospital.in
Website: http://www.parkhospital.in/
Detail Registrar
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: parkmedi.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
The Park Medi World IPO was a ₹920 crore book-built issue, open from December 10–12, 2025, and listed on BSE and NSE on December 17, 2025.
The issue price was ₹162 per share with a lot size of 92 shares, requiring a minimum retail investment of ₹14,904 at the upper price band.
The IPO comprised a fresh issue worth ₹770 crore and an offer for sale of ₹150 crore, aiming to fund expansion, debt repayment, acquisitions, and general corporate purposes.
Park Medi World operates 14 NABH-accredited multi-super speciality hospitals across North India, offering over 30 medical specialties with approximately 3,000 beds and strong critical care infrastructure.
The company reported strong profitability, a 40% PAT growth in FY25, healthy margins, experienced management, and a diversified payer mix, supporting sustainable growth in healthcare services.
Compare:
